Matrixyl 3000 / Pal-GHK/ Palmitoyl Tripeptide-1

99% up by HPLC

Product categories

New Products

Product Details

Product Information

Product name	Matrixyl 3000 （Pal-GHK (2:1) Pal-GQPR）
Alias	Pentapeptide-3, Leuphasyl, Palmitoyl Pentapeptide, Pal-KTTKS Palmitoyl Tripeptide-1
Sequence	Pal-GlyHis-Lys-OH / Pal-Gly-Gln-Pro-Arg-OH
Molecular Formula	C30H54N6O5
Molecular Weight	888.99
Quality Standard	99% up by HPLC
Appearance	White powder

COA of Matrixyl 3000 (Pal-GHK (2:1) Pal-GQPR)

1) COA of Pal-GHK:

Product Name	palmitoyl oligopeptide(Pal-GHK / palmitoyl-GHK)
Molecular Formula	C30H54N6O5	Molecular Weight	578.8
Sequence	Pal-GlyHis-Lys-OH

TEST ITEMS	SPECIFICATION	RESULT
Appearance	White or Off-white powder	White powder
Identity	Monoisotopic Mass:578.8±1.0	578.3
Peptide Purity (By HPLC)	≥ 98.0% by area integration	98.2%
Water Content	≤ 5.0%	1.5%
HACContent (By HPLC)	≤ 15.0%	7.8%

2) COA of Pal-GQPR:

Product Name	Palmitoyl Tetrapeptide -3 (Palmitoyl-GQPR)
Molecular Formula	C34H62N8O7	Molecular Weight	694.9
Sequence	Pal-Gly-Gln-Pro-Arg-OH

TEST ITEMS	SPECIFICATION	RESULT
Appearance	White or Off-white powder	White powder
Identity	Monoisotopic Mass:694.9±1.0	694.3
Peptide Purity (By HPLC)	≥ 95.0% by area integration	98.2%
Water Content	≤ 5.0%	3.8%
HACContent (By HPLC)	≤ 15.0%

Usage

Function of Matrixyl 3000

1. Anti-aging matrixyl 3000 powder

Matrixyl 3000 is an advanced formulation of the yearly edition of Matrixyl which has proven to be one of the best collagen boosters skin repair systems found in the skin care market recently.

On this site we are going to take a closer look at this compound and explain exactly how it can help you with your overall skin care, anti aging and wrinkle removal.

2. What is Matrixyl 3000?

Matrixyl 3000 is a combination of two synthetic peptides named palmitoyl tetrapeptide and Palmitoyl Oligopeptide, derived mostly from essential fatty acids and red wine extracts, and is either found alone or in combination with other ingredients in various skin-care products and creams. These peptides helps the body to synthesize collagen, and add extra moisture to the skin so it will become much easier for the skin cells to rejuvenate and repair broken skin.

When we grow older our natural production of collagen and moisture will start to decrease and more wrinkles will appear because there is not material available for the skin cells to perform a skin repair that completely will remove wrinkles and other signs of aging, using a cream that contain Matrixyl 3000 you can reverse that development and ensure that your skin cells will have enough collagen and moisture available to perform a far better rejuvenation and skin repair which will result in smoother skin, less wrinkles and a younger appearance.

Hot Tags : Palmitoyl Tripeptide-1 matrixyl 3000 powder matrixyl 3000 argireline Pal-GHK matrixyl 3000 peptide matrixyl 3000

Send A Message

Previous : Nonapeptide-1 158563-45-2

Related Products

Liraglutide 204656-20-2

Product Information Product name Liraglutide Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu- Glu-Gly-Gln-Ala-Ala-Lys[N6-[N-(1-oxohexadecyl)-L-γ-glutamyl]- -Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH CAS No. 204656-20-2 Molecular Formula C172H265N43O51 Molecular Weight 3751.20 Storage 2~8℃ Appearance White to off-white crystalline powder COA of Liraglutide Test Specification Results Appearance: White to off-white crystalline powder or lumps White powder Identity: 3751.2±1.0 3751.1 Purity (By HPLC) : Not Less than 98.0%; 99.51% Residual solvents: ≤0.25%total; ≤0.1%individual; ≤0.01%CH2CN Complies Related Peptide Total Impurity ≤ 2.0% Largest Single Impurity ≤ 1.0% TI =0.41% LSI =0.25% Peptide Content: Not Less than 85.0% 87.7% Water (K.F.): Not more than 5% 4.2% Acetate acid: Not more than 10% 8.1% Bacterial Endotoxins Not more than 50IU/mg Complies Usage Function and Usage of Liraglutide 204656-20-2 1、 Type 2 diabetes Liraglutide improves control of blood glucose.It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion. In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over more traditional therapies for type 2 diabetes: · Liraglutide acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk of hypoglycemia. · Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies). · Liraglutide decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride. · Liraglutide lowers blood triglyceride levels. 2、Obesity Liraglutide has been approved as an injectable adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients. The specified criteria are an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight), in the presence of at least one weight-related comorbid condition (e.g.hypertension, type 2 diabetes mellitus, or dyslipidemia). In late 2014, data were reported from the SCALE™ Obesity and Prediabetes trial, which is a randomised, double-blind, placebo-controlled, multinational trial in non-diabetic people with obesity and non-diabetic people who are overweight with comorbidities. In this phase 3a trial, there were 3,731 participants randomised to treatment with liraglutide 3 mg or placebo, both in combination with diet and exercise. Those who completed the 56-week trial achieved an average weight loss of 9.2%, to be compared with a 3.5% reduction in the placebo group.